Friday, September 30, 2022


Biotechnology News Magazine

DW Healthcare Partners Invests in Bio Agri Mix

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

DW Healthcare Partners (“DWHP”) a healthcare-focused private equity firm, announced the completion of its investment in Bio Agri Mix, LP (“Bio Agri Mix” or the “Company”).

Bio Agri Mix is Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble medications for livestock. Since 1983, the Company has supplied feed mills and producers with quality products to improve livestock health.

“Over the years, Bio Agri Mix has developed a truly unique footprint across Canada by expanding their product portfolio and supplying the market in a consistent and methodical basis,” said Eric Moore, Principal at DWHP. “We are excited to have Bio Agri Mix continue under Paul Lake and Rob Bell’s leadership where we will continue to expand our product portfolio to provide more solutions to our customers.”

“We are thrilled to be partnering with Paul Lake, Rob Bell, and the rest of the team at Bio Agri Mix,” said Andrew Carragher, Founder and Managing Partner at DWHP. “They have a proven track record of growth and we are looking forward to supporting them as the business continues to scale. Bio Agri Mix represents DWHP’s third investment in the animal health pharmaceutical space and we are excited to expand our footprint in the sector.”

“The team at Bio Agri Mix is excited to partner with DW Healthcare Partners to continue the growth of the Company and our quest to exceed customer expectations as we supply the North American livestock industry with animal health solutions,” said Robert Bell, Chief Executive Officer at Bio Agri Mix.

“As a founder of Bio Agri Mix, it is gratifying to see DW Healthcare Partners’ passion for the company as we continue our growth in the animal health industry,” said Paul Lake, Executive Chairman at Bio Agri Mix.

Concurrent with the close, Andrew Carragher, Eric Moore, and Paul Hays will join Robert Bell and Paul Lake on the Board of Directors at Bio Agri Mix. Bio Agri Mix represents the fifth investment in DWHP’s fifth fund.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine